Evosep has unveiled Evosep Proteomics, a new ecosystem designed to standardize and scale liquid chromatography-mass spectrometry (LC-MS) based proteomics for both research and drug development. This initiative introduces the Evokit sample preparation kits and the Evosep Lupo Sample Preparation System, which together create a comprehensive platform focused on reproducibility and scalability. The goal is to overcome the challenges posed by current fragmented processes and manual variability, which hinder the translation of proteomic insights into impactful scientific and therapeutic applications. CEO Morten Bern emphasized the need for standardized, low-variance proteomics data to support AI-driven drug development. The platform aims to deliver reliable data at a target cost of approximately $10 per sample, facilitating routine use in biomarker discovery and large-scale drug development. By addressing upstream variability in sample preparation, Evosep Proteomics promises to enhance the quality and comparability of proteomic data across studies, ultimately accelerating drug discovery and improving patient care.